Joinn Laboratories(China)Co.,Ltd. (603127.SS)
CNY 17.42
(0.87%)
CNY 17.42
(0.87%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 85.79 Million CNY | -2.18% |
| 2022 | 87.7 Million CNY | -7.99% |
| 2021 | 95.32 Million CNY | 289.77% |
| 2020 | 24.45 Million CNY | 9.56% |
| 2019 | 22.32 Million CNY | 135.09% |
| 2018 | 9.49 Million CNY | 0.0% |
| 2017 | - CNY | 0.0% |
| 2016 | - CNY | 0.0% |
| 2015 | - CNY | -100.0% |
| 2014 | 49 Million CNY | -22.22% |
| 2013 | 63 Million CNY | -46.66% |
| 2012 | 118.1 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 38.69 Million CNY | -42.39% |
| 2024 Q1 | 63.49 Million CNY | -25.99% |
| 2024 Q2 | 56.88 Million CNY | -10.41% |
| 2023 Q4 | 85.79 Million CNY | -2.68% |
| 2023 Q1 | 89.45 Million CNY | 2.0% |
| 2023 FY | 85.79 Million CNY | -2.18% |
| 2023 Q3 | 88.15 Million CNY | 9.63% |
| 2023 Q2 | 80.41 Million CNY | -10.11% |
| 2022 Q4 | 87.7 Million CNY | -9.96% |
| 2022 FY | 87.7 Million CNY | -7.99% |
| 2022 Q3 | 97.4 Million CNY | 9.35% |
| 2022 Q2 | 89.07 Million CNY | 0.65% |
| 2022 Q1 | 88.49 Million CNY | -7.16% |
| 2021 Q3 | 68.2 Million CNY | -6.32% |
| 2021 Q1 | 77.27 Million CNY | 215.99% |
| 2021 FY | 95.32 Million CNY | 289.77% |
| 2021 Q2 | 72.8 Million CNY | -5.79% |
| 2021 Q4 | 95.32 Million CNY | 39.76% |
| 2020 FY | 24.45 Million CNY | 9.56% |
| 2020 Q3 | 26.22 Million CNY | -5.7% |
| 2020 Q4 | 24.45 Million CNY | -6.75% |
| 2020 Q2 | 27.81 Million CNY | 13.1% |
| 2020 Q1 | 24.58 Million CNY | 10.15% |
| 2019 Q1 | - CNY | 0.0% |
| 2019 FY | 22.32 Million CNY | 135.09% |
| 2019 Q4 | 22.32 Million CNY | 0.0% |
| 2019 Q3 | - CNY | 0.0% |
| 2019 Q2 | - CNY | 0.0% |
| 2018 Q4 | - CNY | 0.0% |
| 2018 Q2 | - CNY | 0.0% |
| 2018 Q1 | - CNY | 0.0% |
| 2018 FY | 9.49 Million CNY | 0.0% |
| 2018 Q3 | - CNY | 0.0% |
| 2017 Q2 | - CNY | 0.0% |
| 2017 Q3 | - CNY | 0.0% |
| 2017 FY | - CNY | 0.0% |
| 2017 Q1 | - CNY | 0.0% |
| 2017 Q4 | - CNY | 0.0% |
| 2016 FY | - CNY | 0.0% |
| 2016 Q4 | - CNY | 0.0% |
| 2015 FY | - CNY | -100.0% |
| 2014 FY | 49 Million CNY | -22.22% |
| 2013 FY | 63 Million CNY | -46.66% |
| 2012 FY | 118.1 Million CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Shanghai Runda Medical Technology Co., Ltd. | 6.85 Billion CNY | 98.748% |
| WuXi AppTec Co., Ltd. | 5.75 Billion CNY | 98.509% |
| Autobio Diagnostics Co., Ltd. | 1.03 Billion CNY | 91.736% |
| Thalys Medical Technology Group Inc. | 1.05 Billion CNY | 91.838% |
| Guangzhou Kingmed Diagnostics Group Co., Ltd. | 578.98 Million CNY | 85.182% |
| Chemclin Diagnostics Co., Ltd. | 234.6 Million CNY | 63.431% |